In the context of chronic infection with HBV, PD-1 blockade increases T cell proliferation and the production of interferon-γ (IFN-γ) and IL-2 by HBV-specific CD8+ T cells taken from both the peripheral blood and livers of patients with chronic hepatitis B (55). The gene discussed is CD8A; the disease is chronic hepatitis B virus infection.